XOMAP (STOCKS)
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
$26.400000
-0.070000 (-0.26%)
Prev close: $26.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Owen Patrick Hughes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $436.26M
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.26 | $-0.16 | +0.4181 | +264.45% |
|
Sep 2025 (Q3)
|
$0.70 | $-0.04 | +0.7408 | +1,815.69% |
|
Jun 2025 (Q2)
|
$0.44 | $-0.23 | +0.6651 | +295.47% |
|
Mar 2025 (Q1)
|
$0.06 | $-0.30 | +0.3646 | +119.70% |
Financial Statements
| Revenues | $52.15M |
| Benefits Costs and Expenses | $20.33M |
| Costs And Expenses | $20.33M |
| Operating Expenses | $40.77M |
| Research and Development | $1.71M |
| Other Operating Expenses | $39.05M |
| Operating Income/Loss | $11.38M |
| Income/Loss From Continuing Operations After Tax | $31.71M |
| Income/Loss From Continuing Operations Before Tax | $31.82M |
| Income Tax Expense/Benefit | $103.00K |
| Income Tax Expense/Benefit, Deferred | $103.00K |
| Net Income/Loss | $31.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $31.71M |
| Net Income/Loss Available To Common Stockholders, Basic | $18.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $20.86M |
| Preferred Stock Dividends And Other Adjustments | $13.20M |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $7.67M |
| Basic Earnings Per Share | $1.53 |
| Diluted Earnings Per Share | $1.46 |
| Basic Average Shares | 12,081,000 |
| Diluted Average Shares | 17,982,000 |
| Assets | $272.70M |
| Current Assets | $117.26M |
| Noncurrent Assets | $155.44M |
| Fixed Assets | $21.00K |
| Intangible Assets | $44.76M |
| Other Non-current Assets | $110.66M |
| Liabilities | $168.74M |
| Current Liabilities | $34.82M |
| Accounts Payable | $2.21M |
| Other Current Liabilities | $32.61M |
| Noncurrent Liabilities | $133.92M |
| Redeemable Noncontrolling Interest | $20.02M |
| Redeemable Noncontrolling Interest, Preferred | $20.02M |
| Equity | $83.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $83.94M |
| Temporary Equity | $20.02M |
| Temporary Equity Attributable To Parent | $20.00M |
| Liabilities And Equity | $272.70M |
| Net Cash Flow From Operating Activities | $2.87M |
| Net Cash Flow From Operating Activities, Continuing | $2.87M |
| Net Cash Flow From Investing Activities | $50.89M |
| Net Cash Flow From Investing Activities, Continuing | $50.89M |
| Net Cash Flow From Financing Activities | -$26.46M |
| Net Cash Flow From Financing Activities, Continuing | -$26.46M |
| Net Cash Flow | $27.29M |
| Net Cash Flow, Continuing | $27.29M |
| Comprehensive Income/Loss | $31.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $31.69M |
| Other Comprehensive Income/Loss | -$20.00K |